市場調查報告書

止血劑·組織密封膠的全球市場的未來預測

Global Hemostats and Tissue Sealants Market Forecast 2019-2027

出版商 Inkwood Research 商品編碼 750058
出版日期 內容資訊 英文 135 Pages
商品交期: 2-3個工作天內
價格
Back to Top
止血劑·組織密封膠的全球市場的未來預測 Global Hemostats and Tissue Sealants Market Forecast 2019-2027
出版日期: 2019年02月16日內容資訊: 英文 135 Pages
簡介

本報告提供全球止血劑及組織密封膠 (組織密封膠) 市場未來展望相關分析,提供產品概要和市場結構,主要的推動及阻礙市場要素,整體市場規模趨勢預測 (今後9年份),各產品及地區別詳細趨勢,市場競爭環境,主要企業簡介等調查。

第1章 分析範圍

第2章 分析方法

第3章 摘要整理

第4章 市場動態

  • 市場範圍和定義
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第5章 各產品的市場

  • 局部止血劑
    • 機械性止血法
    • 活性止血劑
    • 流動性止血劑
  • 黏劑·組織密封膠
    • 合成組織密封膠
      • 氧化再生纖維素
      • 氰基丙烯酸酯黏劑
      • 其他
    • 天然組織密封膠
      • 甲殼素品質/幾丁聚醣系的止血劑
      • 其他
    • 粘連防止產品

第6章 主要指標

  • 波特的五力分析
  • PESTLE/SCOT分析:止血劑·組織密封膠市場
    • 政治·法律上的要素
    • 經濟要素
    • 技術性要素
  • 市場趨勢
  • 市場機會矩陣

第7章 各地區分析

  • 北美 (美國,加拿大)
  • 歐洲 (英國,德國,法國,義大利,西班牙等)
  • 亞太地區 (日本,中國,印度,澳洲,韓國等)
  • 其他的國家 (RoW:南美,中東·非洲)

第8章 競爭環境

  • 市場定位分析
  • 企業簡介
    • ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
      • 企業概要
      • 產品系列
      • SCOT分析
      • 策略部署情形
    • BAXTER INTERNATIONAL INC.
    • B.BRAUN MELSUNGEN AG
    • COHERA MEDICAL INC.
    • C.R. BARD, INC.
    • CRYOLIFE INC.
    • CSL BEHRING
    • HYPERBRANCH MEDICAL TECHNOLOGY, INC. (STRYKER收購完畢)
    • INTEGRA LIFESCIENCES CORP
    • JOHNSON AND JOHNSON
    • MEDTRONIC PLC
    • PFIZER, INC.
    • SMITH AND NEPHEW PLC
    • ZIMMER BIOMET HOLDINGS INC

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 22676

KEY FINDINGS

The global market for hemostats and sealants is predicted to grow at a CAGR of 8.03% between 2019 and 2027. The increasing cases of chronic diseases requiring surgeries are primarily driving the global hemostats and sealants market. The market has been segmented on the basis of its products into topical hemostat and adhesive & tissue sealants. The synthetic skin sealants sub-segment, under the adhesive & tissue sealants category, is flourishing the most in terms of revenues and was valued at $xx million in 2018.

MARKET INSIGHTS

The predicted rise in global geriatric population is expected to drive the growth of hemostasis and tissue sealing market over the forecast period in both the developed economies and emerging economies like that of India and China. The increasing numbers of minimally-invasive cosmetic procedures are expected to propel the number of surgeries in the global healthcare market, which is further expected to propel the market for hemostats and sealants. Nonetheless, the grafting of the sealants in the body can cause serious medical complications, resulting in their increased scrutiny for safety and effectiveness. This can act as a hurdle for the market to overcome.

REGIONAL INSIGHTS

The global market for hemostats and tissue sealants is geographically segmented into several regions, namely, North America, Asia-Pacific, Europe and the countries from the Rest of the World. North America is expected to capture the largest share of the global hemostasis and tissue sealing agents market mainly because of the increasing cases of cardiovascular disorders, diabetes and cancer in this region. The Asia Pacific market has been projected to grow at a good pace during the forecast period owing to the better medical tourism and surgical procedures. The European market is expected to grow due to the upsurge in its geriatric population, which will result in a higher frequency of surgeries being performed.

COMPETITIVE INSIGHTS

Most of the market players operate through segments that can be involved in discovery, development and manufacture of healthcare products. Some of these companies are Advanced Medical Solutions (AMS) Group PLC, Baxter International Inc., B.Braun Melsungen AG, Cohera Medical Inc., C.R. Bard, Inc., Cryolife Inc., CSL Behring, Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Integra Lifesciences Corp., Johnson & Johnson, Medtronic PLC, Pfizer, Inc. and Smith & Nephew PLC.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
    • 3.2.2. SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 4.2.2. INCREASE IN AGING POPULATION
    • 4.2.3. INCREASE IN NUMBER OF SURGERIES
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. STRINGENT REGULATIONS
    • 4.3.2. ADVERSE REACTIONS AND COMPLICATIONS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
    • 4.4.2. ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
    • 4.5.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY

5. MARKET BY PRODUCTS

  • 5.1. TOPICAL HEMOSTAT
    • 5.1.1. MECHANICAL HEMOSTATS
    • 5.1.2. ACTIVE HEMOSTATS
    • 5.1.3. FLOWABLE HEMOSTATS
  • 5.2. ADHESIVE AND TISSUE SEALANTS
    • 5.2.1. SYNTHETIC TISSUE SEALANT
      • 5.2.1.1. OXIDIZED REGENERATED CELLULOSE
      • 5.2.1.2. CYANOACRYLATE ADHESIVES
      • 5.2.1.3. OTHER SYNTHETIC TISSUE SEALANTS
    • 5.2.2. NATURAL TISSUE SEALANT
      • 5.2.2.1. CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
      • 5.2.2.2. OTHER NATURAL TISSUE SEALANT
    • 5.2.3. ADHESION BARRIER PRODUCTS

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCE MODEL
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTE
    • 6.1.3. BARGAINING POWER OF SUPPLIERS
    • 6.1.4. BARGAINING POWER OF BUYERS
    • 6.1.5. THREAT OF COMPETITIVE RIVALRY
  • 6.2. POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SCOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
    • 6.2.1. POLITICAL & LEGAL
    • 6.2.2. ECONOMIC
    • 6.2.3. TECHNOLOGICAL
  • 6.3. MARKET TRENDS
  • 6.4. OPPORTUNITY MATRIX

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. GERMANY
    • 7.2.3. FRANCE
    • 7.2.4. ITALY
    • 7.2.5. SPAIN
    • 7.2.6. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. JAPAN
    • 7.3.2. CHINA
    • 7.3.3. INDIA
    • 7.3.4. AUSTRALIA
    • 7.3.5. SOUTH KOREA
    • 7.3.6. REST OF ASIA PACIFIC
  • 7.4. REST OF THE WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST AND AFRICA

8. COMPETITIVE LANDSCAPE

  • 8.1. MARKET POSITION ANALYSIS
  • 8.2. COMPANY PROFILES
    • 8.2.1. ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
      • 8.2.1.1. COMPANY OVERVIEW
      • 8.2.1.2. PRODUCT PORTFOLIO
      • 8.2.1.3. STRATEGIC INITIATIVES
    • 8.2.2. BAXTER INTERNATIONAL INC.
      • 8.2.2.1. COMPANY OVERVIEW
      • 8.2.2.2. PRODUCT PORTFOLIO
      • 8.2.2.3. SCOT ANALYSIS
      • 8.2.2.4. STRATEGIC INITIATIVES
    • 8.2.3. B.BRAUN MELSUNGEN AG
      • 8.2.3.1. OVERVIEW
      • 8.2.3.2. PRODUCT PORTFOLIO
      • 8.2.3.3. SCOT ANALYSIS
      • 8.2.3.4. STRATEGIC ANALYSIS
    • 8.2.4. COHERA MEDICAL INC.
      • 8.2.4.1. COMPANY OVERVIEW
      • 8.2.4.2. PRODUCT PORTFOLIO
      • 8.2.4.3. STRATEGIC INITIATIVES
    • 8.2.5. C.R. BARD, INC.
      • 8.2.5.1. COMPANY OVERVIEW
      • 8.2.5.2. PRODUCT PORTFOLIO
      • 8.2.5.3. SCOT ANALYSIS
      • 8.2.5.4. STRATEGIC INITIATIVES
    • 8.2.6. CRYOLIFE INC.
      • 8.2.6.1. COMPANY OVERVIEW
      • 8.2.6.2. PRODUCT PORTFOLIO
      • 8.2.6.3. STRATEGIC INITIATIVES
    • 8.2.7. CSL BEHRING
      • 8.2.7.1. COMPANY OVERVIEW
      • 8.2.7.2. PRODUCT PORTFOLIO
      • 8.2.7.3. STRATEGIC INITIATIVES
    • 8.2.8. HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
      • 8.2.8.1. COMPANY OVERVIEW
      • 8.2.8.2. PRODUCT PORTFOLIO
      • 8.2.8.3. STRATEGIC INITIATIVES
    • 8.2.9. INTEGRA LIFESCIENCES CORP
      • 8.2.9.1. COMPANY OVERVIEW
      • 8.2.9.2. PRODUCT PORTFOLIO
      • 8.2.9.3. SCOT ANALYSIS
      • 8.2.9.4. STRATEGIC INITIATIVES
    • 8.2.10. JOHNSON AND JOHNSON
      • 8.2.10.1. COMPANY OVERVIEW
      • 8.2.10.2. PRODUCT PORTFOLIO
      • 8.2.10.3. SCOT ANALYSIS
      • 8.2.10.4. STRATEGIC INITIATIVES
    • 8.2.11. MEDTRONIC PLC
      • 8.2.11.1. COMPANY OVERVIEW
      • 8.2.11.2. PRODUCT PORTFOLIO
      • 8.2.11.3. SCOT ANALYSIS
      • 8.2.11.4. STRATEGIC INITIATIVES
    • 8.2.12. PFIZER, INC.
      • 8.2.12.1. COMPANY PROFILES
      • 8.2.12.2. PRODUCT PORTFOLIO
      • 8.2.12.3. SCOT ANALYSIS
      • 8.2.12.4. STRATEGIC INITIATIVES
    • 8.2.13. SMITH AND NEPHEW PLC
      • 8.2.13.1. MARKET OVERVIEW
      • 8.2.13.2. PRODUCT PORTFOLIO
      • 8.2.13.3. SCOT ANALYSIS
      • 8.2.13.4. STRATEGIC INITIATIVE
    • 8.2.14. ZIMMER BIOMET HOLDINGS INC
      • 8.2.14.1. MARKET OVERVIEW
      • 8.2.14.2. PRODUCT PORTFOLIO
      • 8.2.14.3. SCOT ANALYSIS
      • 8.2.14.4. STRATEGIC INITIATIVES

LIST OF TABLES

  • TABLE 1 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
  • TABLE 3 GLOBAL TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 4 GLOBAL TOPICAL HEMOSTAT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL MECHANICAL HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL ACTIVE HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL FLOWABLE HEMOSTATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL OXIDIZED REGENERATED CELLULOSE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL CYANOACRYLATE ADHESIVES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL OTHER SYNTHETIC TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL NATURAL TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL OTHER NATURAL TISSUE SEALANT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 22 EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 23 ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 24 REST OF THE WORLD HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 25 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
  • TABLE 26 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)

LIST OF FIGURES

  • FIGURE 1 PROCESS OF COAGULATION
  • FIGURE 2 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY REGION 2018-2026 ($ MILLION)
  • FIGURE 3 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
  • FIGURE 4 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
  • FIGURE 17 PORTER'S FIVE FORCE MODEL
  • FIGURE 18 GLOBAL HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 19 THE UNITED STATES HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 20 CANADA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 21 THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 22 GERMANY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 23 FRANCE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 24 ITALY HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 25 SPAIN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 26 REST OF EUROPE HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 27 JAPAN HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 28 CHINA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 INDIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 AUSTRALIA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 SOUTH KOREA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 REST OF ASIA PACIFIC HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 LATIN AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 MIDDLE EAST AND AFRICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
Back to Top